Toggle navigation
Ask Questions
Ask
Answer Questions
Answer
Users
FAQ
Login
Register
Preview 50% of the Answer Below
Due to formatting, images, tables, or paragraphs may be out of place or not shown. Rest assured that they will be included and formatted correctly in your purchased answer.
Details
Question Title:
access to a journal
Go Back to the Question
Answer Preview
Ralph E Dolkart</span><span class="contrib-degrees">, M.D.</span>,</li><li><span class="name">Bernard Halpern</span><span class="contrib-degrees">, XX.X.</span>XXX</li><li><span XXXXX="name">XXXXXX Perlman</span><span XXXXX="XXXXXXX-XXXXXXX">, B.S.</span></li></ol> <h2>Abstract</h2> <p>XXX XXXXXX for XXX XXXXXXXXX XXXXXXXXX and severity of infections in XXXXXXXX XXXXXXXX has never been XXXXXXXXXXXXXX XXXXXXXXX. This investigation XXX XXXXXXXX XX study XXX circulating antibody XXXXXXXX in XXXXXXX diabetic, insulin treated diabetic and XXXXXX XX-1 mice injected XXXX bovine XXXXX XXXXXXX. XXXX XXXXX XXXXXXX XXXXXXX XXXX alloxan XXX had elevated XXXXX XXXXXXX XXXXXX (XXX XX./100 ml. or XXXXXX) were XXXXXXXX in the study, together with a group XX normal animals. XXXXXXX XXXX bled XXXX XXX orbital XXXXX and the serum XXXXXXXX XXX XXXXXXX XXXXXXX capacity XX XXX, XXXXXXX concentration and serum XXXXXXXX. XXX was iodinated with I-131 XXX XXX XXXXXXX XXXXXXX capacity XX each XXXXX XXXXXX XXX XXXXXXXXXX XX XXXXXXXXXX XX XXX XXXXXXXX XXXXX XX X ml. of XXXXXXXXX XXXXX. XXX studies demonstrate that there is no XXXXXXXXXXX difference in XXXXXXXX XXXXXXXX of alloxan treated XXXX, XXXXXXX treated mice given insulin XXX XXXXXX XXXX when immunized with XXX XXXXX the XXXXXXXXXX of the experiments. XX the alloxan XXXXXXX mouse XXX XX considered a laboratory model of diabetes mellitus in XXX, XXX XXXXXXX XXXXXXXXX XXXXXX would XX consistent with those studies of diabetics which XXXX shown no XXXXXXX XXXXXX in XXXXX immune XXXXXXX.</p> <ul><li>XXXXXXXXX &XXXX; 1971 by the American Diabetes Association</li></ul>">
Attachment #1 Preview
